NCT04940637 2023-05-12
UNITO-001
University of Turin, Italy
Phase 2 Unknown
Clinical Trials
9 trialsNCT02349958 2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2 Unknown
NCT01569919 2013-03-12
SKOPOS
Wales Cancer Trials Unit
Phase 2 Unknown
NCT00996385 2011-10-31
Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
Columbia University
Phase 2 Unknown
NCT01281800 2011-01-24
AGILI
Institute of Oncology Ljubljana
Phase 2 Unknown
NCT00794859 2009-08-04
SMS
King's College London
Phase 2 Unknown
NCT00454519 2009-02-13
IPHC
Wuhan University
Phase 2 Unknown
NCT00685204 2008-05-28
TL139
Taxolog Inc.
Phase 2 Unknown
NCT00551252 2007-10-30
A Phase II Study of the Association of Glivec® Plus Gemzar® in Patients With Unresectable, Refractory, Malignant Mesothelioma
Gruppo Italiano MEsotelioma
Phase 2 Unknown